| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Developmental Endocrinology Branch (J.W., J.Z., C.B.), NICHD, NIH, Bethesda, Maryland 20892; Cardiovascular Research Department (L.P.-B.), Genentech Inc., San Francisco, California
Address all correspondence and requests for reprints to: Carolyn Bondy, M.D., NIH, 10 Center Drive, Building 10, Room 10N 262, Bethesda, Maryland 20892.
| Abstract |
|---|
|
|
|---|
85% of
wt at P10 and
56% at P40. Igf1-/- kidney,
spleen and liver are slightly but significantly increased in size
relative to the degree of reduction in Igf1-/- body
weight. These data demonstrate that Igf1 has two major phases or modes
of growth promotion. There is an early, growth hormone (GH)-independent
Igf1 growth augmentation during perinatal development, responsible for
about 35% of growth prior to P20. Then there are later effects due to
GH-induced Igf1, which are responsible for increasing animal size by
100% between P20 and 40. The fact that there is virtually no
GH-induced growth in the Igf1-/- mice supports the view
that Igf1 mediates GHs major effects on somatic growth. Finally, this
study shows that Igf1-/- has discordant effects on pulmonary and
cardiac growth parameters, with relative hypoplasia of Igf1-/-lungs and hypertrophy of Igf1-/- hearts. Received March 4, 1999.
This article has been cited by other articles:
![]() |
J. van den Berg, E. M. N. Bannink, P. A. Wielopolski, W. C. J. Hop, L. van Osch-Gevers, P. M. T. Pattynama, S. M. P. F. de Muinck Keizer-Schrama, and W. A. Helbing Cardiac Status after Childhood Growth Hormone Treatment of Turner Syndrome J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2553 - 2558. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Stoffel, B. Jenke, B. Holz, E. Binczek, R. H. Gunter, J. Knifka, J. Koebke, and A. Niehoff Neutral Sphingomyelinase (SMPD3) Deficiency Causes a Novel Form of Chondrodysplasia and Dwarfism That Is Rescued by Col2A1-Driven smpd3 Transgene Expression Am. J. Pathol., July 1, 2007; 171(1): 153 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Frank Growth Hormone, Insulin-Like Growth Factor I, and Growth: Local Knowledge Endocrinology, April 1, 2007; 148(4): 1486 - 1488. [Full Text] [PDF] |
||||
![]() |
C. Moerth, M. R. Schneider, I. Renner-Mueller, A. Blutke, M. W. Elmlinger, R. G. Erben, C. Camacho-Hubner, A. Hoeflich, and E. Wolf Postnatally Elevated Levels of Insulin-Like Growth Factor (IGF)-II Fail to Rescue the Dwarfism of IGF-I-Deficient Mice except Kidney Weight Endocrinology, January 1, 2007; 148(1): 441 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ning, A. G. P. Schuller, S. Bradshaw, P. Rotwein, T. Ludwig, J. Frystyk, and J. E. Pintar Diminished Growth and Enhanced Glucose Metabolism in Triple Knockout Mice Containing Mutations of Insulin-Like Growth Factor Binding Protein-3, -4, and -5 Mol. Endocrinol., September 1, 2006; 20(9): 2173 - 2186. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Davis and R. C. M. Simmen Genetic parameter estimates for serum insulin-like growth factor I concentrations, and body weight and weight gains in Angus beef cattle divergently selected for serum insulin-like growth factor I concentration J Anim Sci, September 1, 2006; 84(9): 2299 - 2308. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Cheng, V. Tseng, J. Wang, D. Wang, L. Matyakhina, and C. A. Bondy Tau Is Hyperphosphorylated in the Insulin-Like Growth Factor-I Null Brain Endocrinology, December 1, 2005; 146(12): 5086 - 5091. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mazerbourg, D. M. Bouley, S. Sudo, C. A. Klein, J. V. Zhang, K. Kawamura, L. V. Goodrich, H. Rayburn, M. Tessier-Lavigne, and A. J. W. Hsueh Leucine-Rich Repeat-Containing, G Protein-Coupled Receptor 4 Null Mice Exhibit Intrauterine Growth Retardation Associated with Embryonic and Perinatal Lethality Mol. Endocrinol., September 1, 2004; 18(9): 2241 - 2254. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Huang, S.-O. Kim, N. Yang, J. Jiang, and S. J. Frank Physical and Functional Interaction of Growth Hormone and Insulin-Like Growth Factor-I Signaling Elements Mol. Endocrinol., June 1, 2004; 18(6): 1471 - 1485. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Michael, S. Haq, X. Chen, E. Hsich, L. Cui, B. Walters, Z. Shao, K. Bhattacharya, H. Kilter, G. Huggins, et al. Glycogen Synthase Kinase-3{beta} Regulates Growth, Calcium Homeostasis, and Diastolic Function in the Heart J. Biol. Chem., May 14, 2004; 279(20): 21383 - 21393. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. M. Salih, G. Tripathi, C. Holding, T. A. M. Szestak, M. I. Gonzalez, E. J. Carter, L. J. Cobb, J. E. Eisemann, and J. M. Pell Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice PNAS, March 23, 2004; 101(12): 4314 - 4319. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Colao, D. Ferone, P. Marzullo, and G. Lombardi Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management Endocr. Rev., February 1, 2004; 25(1): 102 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, K. Iida, J. O'Neil, P. Zhang, S.'a. Li, A. Frank, A. Gabai, F. Zambito, S.-H. Liang, C. J. Rosen, et al. PERK eIF2{alpha} Kinase Regulates Neonatal Growth by Controlling the Expression of Circulating Insulin-Like Growth Factor-I Derived from the Liver Endocrinology, August 1, 2003; 144(8): 3505 - 3513. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Shiojima, M. Yefremashvili, Z. Luo, Y. Kureishi, A. Takahashi, J. Tao, A. Rosenzweig, C. R. Kahn, E. D. Abel, and K. Walsh Akt Signaling Mediates Postnatal Heart Growth in Response to Insulin and Nutritional Status J. Biol. Chem., September 27, 2002; 277(40): 37670 - 37677. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Holzenberger, G. Hamard, R. Zaoui, P. Leneuve, B. Ducos, C. Beccavin, L. Perin, and Y. Le Bouc Experimental IGF-I Receptor Deficiency Generates a Sexually Dimorphic Pattern of Organ-Specific Growth Deficits in Mice, Affecting Fat Tissue in Particular Endocrinology, October 1, 2001; 142(10): 4469 - 4478. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Camarero, C. Avendano, C. Fernandez-Moreno, A. Villar, J. Contreras, F. de Pablo, J. G. Pichel, and I. Varela-Nieto Delayed Inner Ear Maturation and Neuronal Loss in Postnatal Igf-1-Deficient Mice J. Neurosci., October 1, 2001; 21(19): 7630 - 7641. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fruchtman, L. Jackson, and R. Borski Insulin-Like Growth Factor I Disparately Regulates Prolactin and Growth Hormone Synthesis and Secretion: Studies Using the Teleost Pituitary Model Endocrinology, August 1, 2000; 141(8): 2886 - 2894. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Holzenberger, P. Leneuve, G. Hamard, B. Ducos, L. Perin, M. Binoux, and Y. Le Bouc A Targeted Partial Invalidation of the Insulin-Like Growth Factor I Receptor Gene in Mice Causes a Postnatal Growth Deficit Endocrinology, July 1, 2000; 141(7): 2557 - 2566. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Borski, W. Tsai, R. Demott-Friberg, and A. L. Barkan Induction of growth hormone (GH) mRNA by pulsatile GH-releasing hormone in rats is pattern specific Am J Physiol Endocrinol Metab, May 1, 2000; 278(5): E885 - E891. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Liu, S. Yakar, and D. LeRoith Conditional Knockout of Mouse Insulin-Like Growth Factor-1 Gene Using the Cre/loxP System Experimental Biology and Medicine, April 1, 2000; 223(4): 344 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Pell, R. A. Hill, C. E. H. Stewart, C. R. Weston, and H. C. Flick-Smith Enhancement of Insulin-Like Growth Factor I Activity by Novel Antisera: Potential Structure/Function Interactions Endocrinology, February 1, 2000; 141(2): 741 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Liu and D. LeRoith Insulin-Like Growth Factor I Is Essential for Postnatal Growth in Response to Growth Hormone Endocrinology, November 1, 1999; 140(11): 5178 - 5184. [Abstract] [Full Text] |
||||
![]() |
C. Lu, G. Schwartzbauer, M. A. Sperling, S. U. Devaskar, S. Thamotharan, P. D. Robbins, C. F. McTiernan, J.-L. Liu, J. Jiang, S. J. Frank, et al. Demonstration of Direct Effects of Growth Hormone on Neonatal Cardiomyocytes J. Biol. Chem., June 15, 2001; 276(25): 22892 - 22900. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |